Content Type: Article

  • The Legal Effect of IRS Pronouncements on Virtual Currency

    The Legal Effect of IRS Pronouncements on Virtual Currency

    ARTICLE / CLIENT ALERT

    The Legal Effect of IRS Pronouncements on Virtual Currency

    June 3, 2020

    Read time: 9 min

    Key takeaways
    Overview

    Given limited guidance by US tax authorities regarding taxation of virtual currency activities, taxpayers with such holdings may find themselves in uncharted territory as to whether to take positions that are contrary to IRS pronouncements. This article explores relevant notices, rulings and FAQs, and reviews the types of deference that courts tend to put on different types of IRS interpretations and guidance.

    In depth

    Taxpayers who hold virtual currency have limited guidance as to the taxation of their activities. As of the date of this article, government advice is limited to US Internal Revenue Service (IRS) Notice 2014-21 (2014-16 I.R.B. 938), Revenue Ruling 2019-24 and 2019 Frequently Asked Questions (IR-2019-167). No specific Code sections or Treasury regulations address virtual currency. This means that taxpayers can follow the limited guidance about virtual currency available if they agree with the IRS’s positions. But what if they don’t agree? Can taxpayers choose to take tax positions that are contrary to IRS pronouncements? The answer is yes, but there can be consequences to their decisions.

    This article explores the legal effect of the above-mentioned Notice, Ruling and FAQs about virtual currency, explaining the sort of deference that courts tend to put on different types of IRS pronouncements.

    IRS Interpretive Role

    The IRS’s role “in administering the tax laws enacted by the Congress” is to translate them into detailed regulations, rules and procedures. To do this, the IRS’s Office of Chief Counsel releases various “documents and publications that provide guidance to taxpayers.” Rulings, Notices and FAQs are among the types of publications and information that the IRS issues.

    The IRS is a bureau of the US Department of the Treasury. In the US legal system, both the Treasury Department and the IRS are part of the executive branch and help the US president administer federal tax laws. The US Constitution grants the US Congress the power to legislate tax laws. Given the complexity of the US tax system, however, Congress often delegates some of that rulemaking authority to the Treasury, which in turn issues Treasury regulations that can have the force of law. The IRS issues many types of pronouncements of varying legal weight and precedential value. Thus, when judging the legal weight of any IRS action or pronouncement, it is necessary to consider whether the Treasury is acting pursuant to a congressional delegation of power to make binding tax rules or acting pursuant to general executive branch powers to enforce the law.

    The Treasury cannot unilaterally make binding tax law unless the Congress has specifically delegated rulemaking authority to it. Therefore, short of working with the Treasury to enact Treasury regulations, the IRS only has the authority to provide taxpayers with its views on the proper interpretations of tax laws and to challenge—on audit (subject to judicial review)—what it views as abusive or incorrect tax positions that taxpayers take on their tax returns. If a taxpayer challenges the IRS’s position in court, the IRS must convince the court that its tax position is the correct one for the court to accept.

    Judicial Deference Given to Rulings, Notices and FAQs

    As a rough rule of thumb, federal courts tend to give Treasury and IRS pronouncements different levels of deference under various doctrines named after Supreme Court cases. In general, there are three levels of deference that courts apply to Treasury regulations and IRS guidance. The highest deference is given to Treasury regulations that include a reasonable or permissible interpretation of an ambiguous statute. This is referred to as Chevron deference (Chevron, 467 U.S. 837 (1984)).

    The next level down in deference is Skidmore deference, which is for administrative pronouncements other than Treasury regulations. The Skidmore doctrine directs courts to take into account the IRS’s experience and expertise. Under Skidmore deference, the courts retain their ability to ignore the IRS’s views—even if reasonable—if the courts believe a better interpretation of tax law is to the contrary (323 U.S. 134 (1944); IRS pronouncements do not receive the higher level of deference provided under Chevron deference, which typically applies to Treasury regulations).

    The last level of deference is referred to as Aver or Seminole Rock deference. This deference is given to agency interpretations of their own regulations that should control unless the interpretations are “plainly erroneous or inconsistent with the regulation” (Aver, 519 U.S. 452 (1997), Seminole Rock, 325 U.S. 410 (1945)).

    Under these different standards for deference, courts give lower deference to IRS pronouncements than they do to Treasury regulations, only according such pronouncements with the weight that is warranted given the persuasiveness of the IRS’s positions (U.S. v. Mead Corporation, 533 U.S. 218 (2001)). And, the recent Supreme Court decision in Kisor v. Wilkie (Kisor v. Wilkie, No. 18-15, 588 U.S. ___ (2019)) is likely to have an impact on the deference courts give to ambiguous regulations.

    This brings us back to the government guidance that is currently available with respect to virtual currency. The remainder of this article applies these doctrines to the Revenue Ruling, the Notice and FAQs.

    Revenue Rulings

    A revenue ruling is published in the Internal Revenue Bulletin by the IRS National Office as an official interpretation of the Code, related statutes, tax treaties and Treasury regulations. A revenue ruling sets out the IRS’s conclusions on how the law is applied to a specific set of facts. They are issued in reply to specific taxpayer requests for guidance and to address factual situations that the IRS wants to speak to. Taxpayers can rely on rulings as authoritative and as precedent because the IRS (but not taxpayers) is bound by them (GAO, Highlights of GAO–16-720, “Treasury and OMB Need to Reevaluate Long-Standing Exemptions of Tax Regulations and Guidance,” September 2016).

    Although courts need not view rulings as being as authoritative as Treasury regulations, rulings can be treated as more persuasive or authoritative than notices because rulings are the result of more deliberation, come from the National Office and apply the IRS’s interpretation of the law to a specific set of facts. Although rulings do not bind a court, taxpayers whose circumstances are substantially the same as those described in a ruling can rely on it without fear of penalty. Taxpayers with different circumstances are free to ignore the ruling. And courts can reject the positions taken in a ruling.

    IRS Notices

    A notice provides taxpayers with guidance on matters of general importance, often announcing enactment of a regulation or changes to technical tax rules. (The Internal Revenue Bulletin describes itself as “the authoritative instrument of the Commissioner of Internal Revenue for announcing official rulings and procedures of the Internal Revenue Service and for publishing … items of general interest” (1991-1 C.B. iii.).)

    The IRS tends to use notices to get its views out quickly about rapidly evolving areas of the tax law. The IRS might also issue a notice prior to the time when the Treasury issues regulations in an effort to shape taxpayer reporting during the regulatory formation process. Although notices are not controlling legal authority, taxpayers can rely on them as authoritative and as precedent because the IRS is bound by its notices (GAO, “Highlights.”). Notices do not bind a court; they do not have the “full force of law” as do the Code and Treasury regulations. (See Cantwell v. Deutsche Bank Sec., Inc., No. 3:05-CV-1378-D, 2005 U.S. Dist. LEXIS 20597, at *19 n.7 (N.D. Tex. Sept. 21, 2005) noting that “IRS Notices are not binding on this or any court.” See also Guilzon v. Commissioner, 985 F.2d 819, 822 (5th Cir. 1993) finding that notices are not authoritative, and the court should only look to them for guidance when a statute and its legislative history are “completely ambiguous” (emphasis in original).)

    And, notices have less precedential value than a ruling. (See Samonds v. Commissioner, 66 T.C.M. (CCH) 235 (1993) noting that an IRS Notice “is an administrative pronouncement which like a revenue ruling or revenue procedure does not constitute authority for deciding a case in this Court.”) Indeed, although there is very little case law with respect to the deference courts give to notices, the limited authority makes it clear that notices can be accorded less deference than rulings. (See, e.g., Stubbs Overbeck & Associates v. United States, 445 F.2d 1142, 1146-47 (5th Cir. 1971); Neuhoff v. Commissioner, 75 T.C. 36, 46 (1980), “[A]lthough they are entitled to some consideration, they do not control when contrary to statute or the expressed intention of Congress”; True Oil Co. v. C.I.R., 170 F.3d 1294 (10th Cir. 1999) citing Storm Plastics, Inc. v. United States, 770 F.2d 148, 154 (10th Cir. 1985).)

    Notices and revenue rulings are, thus, akin to announcements of the IRS’s litigating position. They are only as strong as the legal authorities cited, the persuasiveness of the IRS’s interpretations and the relevance of the particular facts. Moreover, notices are not predictors of litigation success. (See, e.g., IES Industries, Inc. v. United States, 253 F.3d 350 (8th Cir. 2001) rev’g (in relevant part) 1999 U.S. Dist. LEXIS 22610 (N.D. Iowa 1999) and Compaq Computer Corp. v. Commissioner, 277 F.3d 778 (5th Cir. 2001) rev’g 113 T.C. 214 (1999). In these cases, the respective appeals courts reversed lower-court decisions that adopted the IRS position in Notice 98-5 describing so-called “abusive foreign tax credit tax shelters.”) To have the force and effect of binding law, the Treasury must issue the same content in a regulation. This makes sense because notices and revenue rulings do not involve the same deliberative process, public comment and upper-level Treasury review that is involved in issuing Treasury regulations.

    Thus, although notices are not controlling legal authorities, they have some significance than notices because they represent the IRS’s opinion as to how tax laws should apply to subject transactions.

    FAQs

    FAQs are issued by the IRS as sources of general information. FAQs are not authoritative and do not serve as precedent in tax disputes (GAO, “Highlights”). It is likely that courts would provide even less deference to FAQs than notices or revenue rulings.

    * * * *

    Whether dealing with rulings, notices or FAQs, taxpayers need to determine whether they believe the government’s positions are correct. Taxpayers who disagree with the IRS’s positions should discuss their concerns with their tax advisors to address the consequences to them of taking positions contrary to IRS pronouncements.

    Authors
    More insights

  • COVID-19: Guide for US Businesses

    ARTICLE

    COVID-19: Guide for US Businesses

    June 3, 2020

    Read time: 1 min

    Key takeaways
    Overview
    In depth
    Authors
    More insights

  • COVID Recovery in the Courts: What to Expect as Courts Adapt to the New Normal

    COVID Recovery in the Courts: What to Expect as Courts Adapt to the New Normal

    ARTICLE / CLIENT ALERT

    COVID Recovery in the Courts: What to Expect as Courts Adapt to the New Normal

    June 3, 2020

    Read time: 8 min

    Key takeaways
    Overview

    The world’s courts and judicial systems are reacting to the outbreak of the novel coronavirus (COVID-19) in broadly different ways, presenting litigants with a range of conflicting situations and advice. In some jurisdictions, litigation has essentially frozen: The courts are closed, limitation and prescription periods are suspended and times for appeal have been extended. In other jurisdictions, the courts remain more or less open (albeit with most or all hearings conducted remotely) and time continues to run. This article compares the impact of these measures on current and future disputes involving tax, trusts and estates and family business disputes in the United States, England and Wales, and offshore.

    In depth

    ILLINOIS:

    As most of Illinois (outside of Chicago) began a staged reopening on May 29, 2020, the Illinois Supreme Court has ordered that “Effective June 1, 2020, the Court’s order of March 17, 2020, is modified so that each circuit may return to hearing court matters, whether in person or remotely, according to a schedule to be adopted for each county by the chief judge in each circuit. The circuit courts shall continue, to the extent possible, to allow for appropriate social distancing and attempt to reduce the number of persons appearing personally for court appearances.” (Illinois Supreme Court Order M.R. 30370, entered May 20, 2020.) As of June 1, 2020, each of the 24 Illinois Circuit Courts is issuing its own orders regarding procedures for reopening courtrooms. These orders vary widely. For example:

    On May 28, 2020, the chief judge of the Circuit Court of Cook County issued an amendment to General Administrative Order 2020-01 extending the closure of almost all civil courtrooms until July 6, 2020. Pursuant to G.A.O. 2020-01, hearings in almost all civil matters scheduled prior to July 6 are continued at least 30 days (to a date not more than 30 days after July 6); the Circuit Court of Cook County has limited ability to hold remote hearings by video or telephone conference. E-filing is required (as it was prior to the pandemic), and filing deadlines are not extended.

    By contrast, on the same day, the chief judge of the Circuit Court for the 3rd Circuit in southern Illinois (Madison and Bond Counties) issued Administrative Order 2020-M-14 reopening all courtrooms “for limited court business” effective June 1, 2020. Everyone entering the courthouse is required to wear a mask, and each courtroom will operate on a separate schedule set by the respective judge.

    The three US District Courts in Illinois each have their own orders governing practice and procedures during the pandemic; none of them have reopened their courthouses for non-emergency civil cases. In the Northern District, the Fourth Amended General Order 20-0012 issued May 26, 2020, directs that civil hearings are to be conducted remotely, by video or telephone conference, through July 15, 2020, and no civil jury trials will be conducted before August 3, 2020. In the Central District, Third Amended General Order 20-01 extends the closure of courthouses through June 15, 2020, while in the Southern District, courthouses will remain closed except for special settings through July 5. Unlike some of the previous orders in the US District Courts, none of the latest orders extend filing or other deadlines in civil cases. None of the District Courts in Illinois have released plans for a general reopening of their courthouses.

    NEW YORK:

    New York state courts began the pandemic closed, except for essential applications, and are slowly opening back up, each in different ways and at a different pace. Litigants can now e-file documents, including to commence new cases, which they could not do previously. For cases commenced pre-COVID, case management depends largely on the court, the case and the judge. However, generally speaking, response deadlines are stayed in the lower courts. Statutes of limitations remain tolled by Executive Order. Courts have been holding appearances, including oral arguments, by video, with increasing frequency, though pre-scheduled routine appearances are often adjourned sine die, unless specifically requested by a party. Many courthouses are beginning to open for in-person operations, depending on the region and in accordance with Governor Cuomo’s phased reopening plan. The reopening of electronic filing led to a heavy influx of new cases and other filings, which created an immediate backlog, but resulting delays may be minimized by the fact that the courts used the “time out” to clear the pre-COVID case backlog.

    US TAX DISPUTES:

    Federal tax disputes are heard initially in the US Tax Court, the US Court of Federal Claims or the US District Courts, and on appeal in the federal appeals courts. The Tax Court is the only pre-payment forum where taxpayers may dispute a liability asserted by the IRS, with the Court of Federal Claims and the District Courts limited to hearing refund suits after a taxpayer has paid in full.

    The Tax Court is headquartered in Washington, DC, but typically conducts trial sessions in 74 cities across the country. The Tax Court cancelled upcoming trial sessions as of March 11, 2020, and closed its building on March 18, 2020. The building remains closed and all trial sessions through June 30, 2020, are cancelled. On May 29, 2020, the chief judge issued Administrative Order No. 2020-02, Remote Court Proceedings During COVID-19 Pandemic. Until further notice, all proceedings of the Tax Court will be conducted remotely and public access to the remote proceedings will be available via real-time audio. The Tax Court’s ability to function remotely, however, is limited by one critical rule: All petitions to initiate a case must be filed on paper with the clerk’s office, which then serves IRS Chief Counsel. With the building closed and no mail being delivered, petitions sent to the court have either been returned to the sender or held, creating a large backlog of unopened cases. Given its commitment to functioning remotely for the foreseeable future, the court will likely modify the procedure for initiating a case or develop a system for receiving and processing its mail in the very near future.

    The Court of Federal Claims, also located in Washington, DC, restricted access to its courthouse until further notice and entered an order on March 16, 2020, directing that all proceeding scheduled to occur before June 15, 2020, would be held by telephone or video conference unless the chief judge granted express permission. There is no general order extending deadlines.

    The statuses of the US District Courts and the federal appeals courts vary dramatically because they are located across the country and the courts are individually coordinating with state and local health officials. Both the District Courts and the federal appeals courts handle civil and criminal cases and must be sensitive to the rights of criminal defendants to a speedy trial and timely appeal. The District Courts in particular face the additional challenge of jury trials. In cities where the pandemic has presented the greatest dangers, civil litigants should expect cases to be handled on paper or through remote hearings for quite some time as courts seek to limit the number of people in the courthouses and prioritize criminal hearings.

    ENGLAND, WALES AND OFFSHORE:

    By contrast, the majority of courts remain open for business in England and Wales, albeit remotely. This has been driven largely to avoid a backlog of cases and to ensure continuity of access to justice. Consequently, limitation periods have not been suspended and it is highly unlikely that the courts will retrospectively resurrect time-barred claims because of delays caused by the pandemic. E-filing is largely available in civil courts, and rules have been relaxed to allow parties to agree extensions to filing deadlines for up to 56 days without court approval. The Lord Chief Justice also announced in March 2020 that the default position during the pandemic is that hearings should be conducted remotely if possible. The judiciary has moved quickly to embrace technology and published guidance on when and how remote hearings should operate. Adjournments to permit “in-person” hearings/trials will only be granted if the judge is satisfied that there will be real prejudice to one or all parties (e.g., IT issues or illness). In practice this means that parties will need to adapt to conducting hearings and trials remotely for the foreseeable future.

    Courts in key offshore jurisdictions have also largely remained in operation over this time to deal with urgent business, following short temporary closures at the beginning of the pandemic. Many offshore jurisdictions have temporarily allowed electronic filing and have introduced remote hearings. However, unlike England and Wales, many offshore jurisdictions have encouraged parties to adjourn non-urgent hearings and have generally adjourned trials until such time as they can resume in physical court. On the whole, limitation periods continue to run in offshore jurisdictions except for the Bahamas (where limitation periods are suspended until 30 days after emergency measures are lifted).

    SUMMARY:

    As governments ease lockdown measures begin to ease in their jurisdictions, the judicial systems are slowly reopening and various measure are being put in place to allow “in-person” hearings to resume safely. Court users can expect that courts will impose social distancing measures, compulsory wearing of masks and temperature checks as the norm.

    Much of the guidance published in these jurisdictions since the beginning of the COVID-19 pandemic has already been updated or replaced. As the situation shifts and government advice changes, so will the response of the courts. As a result, all parties in the midst of court proceedings should ensure they stay up to date with the various pieces of guidance issued by courts in their respective jurisdiction

    Authors

    Monica S. Asher

    Partner

    New York – One Vanderbilt Avenue

    More insights

  • Regulated Funds and Activism: SEC Staff Issues No-Action Position on Permissibility of Reliance on State Control Share Acquisition Statutes by Closed-End Funds

    Regulated Funds and Activism: SEC Staff Issues No-Action Position on Permissibility of Reliance on State Control Share Acquisition Statutes by Closed-End Funds

    ARTICLE / CLIENT ALERT

    Regulated Funds and Activism: SEC Staff Issues No-Action Position on Permissibility of Reliance on State Control Share Acquisition Statutes by Closed-End Funds

    June 3, 2020

    Read time: 5 min

    Key takeaways
    Overview

    On May 27, 2020, the staff of the Division of Investment Management of the SEC (“Staff”) withdrew previously issued Staff guidance addressing the relationship between state control share acquisition statutes (“control share statutes”) and the voting requirements of Section 18(i) of the Investment Company Act of 1940, as amended (“1940 Act”), and adopted a new no-action position in its place (“No-Action Position”).[1] Control share statutes have been adopted by approximately half the states in the United States as a defensive measure to protect corporations and their existing shareholders from hostile or speculative takeovers. However, these control share statutes had previously been viewed by the Staff as being inconsistent with Section 18(i), which requires that every share of stock issued by a registered management company must be a “voting stock” and have “equal voting rights” as every other share of outstanding stock.[2]

    The No-Action Position replaces the Staff’s prior position expressed in its letter to Boulder Total Return Fund Inc. (“Boulder Letter”),[3] which discussed the interplay between Section 18(i) and the Maryland Control Share Acquisition Act (“MCSAA”). In the Boulder Letter, the Staff stated that by opting into the MCSAA, which limits the voting rights of control shares except to the extent approved by a Maryland corporation’s shareholders, a closed-end fund would be operating in a manner “inconsistent with the wording of, and purposes underlying, Section 18(i).”[4] Notably, the Staff had articulated its position on an informal basis for several years prior to issuance of the Boulder Letter, which followed court decisions that ran contrary to the Staff’s then-current view on the topic.

    In September 2018, SEC chairman Jay Clayton directed the Staff to review prior Staff statements and documents to determine whether more recent market or other developments provided a basis to modify, rescind or supplement them. As a result, the Staff determined to rescind the Boulder Letter and to take the position that, under certain circumstances, a closed-end fund may opt into a state control share statute without risking an enforcement action against the fund under Section 18(i). The Staff Position requires that the decision to opt-in to or otherwise trigger a control share statute must be the decision of the board of directors of the fund, taken with “reasonable care on a basis consistent with other applicable duties and laws and the duty to the fund and its shareholders generally.”[5] The Staff further notes that fund boards determining whether to opt in to a control share statute must consider “(1) the board’s fiduciary obligations to the fund, (2) applicable federal and state law provisions, and (3) the particular facts and circumstances surrounding the board’s action.”[6] While these factors must be considered by the board of a fund deciding whether to opt in to a control share statute, the No-Action Position now provides a potential path for closed-end funds to opt in to such statutes that was previously blocked under the Boulder Letter.

    The adoption of the Staff’s No-Action Position could have a chilling effect on activism within the closed-end fund space, particularly in view of the many challenges insurgents already face under the 1940 Act. For example, for the many closed-end funds incorporated in Maryland, a simple board resolution would likely permit a fund to opt into the MCSAA, and thereby block an investor from obtaining a meaningful stake of a fund’s outstanding shares. Notably, however, the Staff statement also requests feedback on several questions relating to the impact of control share statutes and other related matters, in order to determine whether additional SEC action involving this matter is warranted. Given this opening, we would expect larger investors, activists and other stakeholders within the closed-end fund space to express their views on both the No-Action Position, as well as the interplay between other anti-takeover measures and the 1940 Act, to help shape the Staff’s views going forward.

    If you have any questions about the content of this Alert, please contact your attorney at Schulte Roth & Zabel or one of the authors.

    Authored by Eleazer Klein, Aneliya S. Crawford, Karen Spiegel and Noah B. Aschen.


    [1] “Control Share Acquisition Statutes,” SEC Staff Statement, May 27, 2020, available here.

    [2] 15 U.S. Code § 80a–18.

    [3] “Boulder Total Return Fund, Inc.,” SEC No-Action Letter, November 15, 2010, available here.

    [4] Id.

    [5] “Control Share Acquisition Statutes,” SEC Staff Statement, May 27, 2020, available here.

    [6] Id.


    This communication is issued by Schulte Roth & Zabel LLP for informational purposes only and does not constitute legal advice or establish an attorney-client relationship. In some jurisdictions, this publication may be considered attorney advertising. ©2020 Schulte Roth & Zabel LLP.

    All rights reserved. SCHULTE ROTH & ZABEL is the registered trademark of Schulte Roth & Zabel LLP.

    In depth
    Authors

    Ele Klein

    Partner

    New York – 919 Third Avenue

    More insights

  • Regulated Funds: SEC Proposes New Fair Valuation Framework

    Regulated Funds: SEC Proposes New Fair Valuation Framework

    ARTICLE / CLIENT ALERT

    Regulated Funds: SEC Proposes New Fair Valuation Framework

    June 3, 2020

    Read time: 20 min

    Key takeaways
    Overview

    On April 21, 2020, the SEC proposed a new rule under the Investment Company Act of 1940, as amended (“1940 Act”), addressing the valuation practices of registered investment companies and business development companies (“regulated funds”).[1] Proposed Rule 2a-5 (“Proposed Rule”) represents an effort to modernize and codify a framework for fair value determination of regulated fund investments for registered investment companies. Most significantly, in a departure from prior SEC guidance and interpretation, and subject to several requirements and the continued oversight of the board, the Proposed Rule would allow a regulated fund’s board to assign the fair value determination of the regulated fund’s investments to the regulated fund’s investment adviser or sub-adviser, rather than requiring the board to make the final determination itself.

    If adopted, the Proposed Rule could provide considerable benefit to regulated funds that invest from time-to-time in illiquid securities that do not have readily available market quotations, particularly when such illiquid investments represent a relatively small percentage of a regulated fund’s overall portfolio.[2] With the assistance of investment advisers, boards of such regulated funds are currently required to engage in a time consuming and intensive process to make fair value determinations for these hard to value investments on a regular basis. Under the Proposed Rule, these boards would retain oversight of the valuation process, but could formally assign the fair value determination with respect to such illiquid assets, including the establishment and application of a fair value methodology, to the regulated fund’s investment adviser.

    Conversely, however, a number of the requirements imposed under the Proposed Rule, including segregating the valuation process from the portfolio management function, may make reliance on the Proposed Rule by regulated funds that primarily invest in illiquid assets, such as business development companies (“BDCs”), less attractive or even impossible. In particular, BDCs and other similar illiquid-focused regulated funds tend to have well-developed procedures for boards to interact with both advisory personnel and third-party valuation firms, where appropriate, as part of the periodic valuation process. As a result, the boards of such regulated funds may be less willing to delegate their responsibilities with respect to, and therefore, potentially reduce their visibility and integral participation in, the valuation process. In addition, advisers to such regulated funds may be unwilling or unable to segregate portfolio management personnel from the valuation process, as would be required under the Proposed Rule.

    In contrast, open-end regulated funds, including mutual regulated funds and exchange-traded regulated funds, may be more likely to take advantage of the flexibility afforded under the Proposed Rule, if adopted. Specifically, such open-end regulated funds would normally only have a small percentage of their respective portfolios invested in illiquid investments, if any. The ability to adopt detailed procedures to permit an open-end regulated fund’s board to delegate the valuation of such illiquid investments to the regulated fund’s adviser would, therefore, allow such regulated funds to more easily and efficiently handle assets that unexpectedly become illiquid, while also treating such investments in a manner that would be more consistent with how liquid investments are presently valued by most open-end regulated funds. In addition, the delegation of fair value determinations provided under the Proposed Rule would ease the burden of setting an open-end regulated fund’s net asset value, and therefore, the value of its investment portfolio, on a daily basis.

    Although the Proposed Rule addresses regulated funds regulated under the 1940 Act, the Proposed Rule and the release proposing the rule (“Release”) may also provide insight into certain valuation-related matters with respect to investment advisers that advise private regulated funds, including relating to potential conflicts of interest in the valuation process. In addition, advisers that primarily advise private regulated funds but also advise or sub-advise regulated funds should familiarize themselves with the provisions of the Proposed Rule and may need to update their valuation procedures to reflect certain requirements of the Proposed Rule.

    Background

    As discussed in the Release, the proper valuation of a regulated fund’s investments plays a crucial role in various aspects of a regulated fund’s operations, including the determination of a regulated fund’s net asset value, which for many regulated funds determines the price at which a regulated fund’s shares are offered and redeemed. Valuation of investments also affects the accuracy of a regulated fund’s asset-based and performance-based fee calculations and impacts a regulated fund’s ability to comply with its investment policies and restrictions. However, the SEC has not formally addressed regulated fund valuation practices since the early 1970s, when it issued Accounting Series Releases Nos. 113 and 118 (“ASRs”) which still provide the basis for determination of fair value of securities today, along with guidance from the Financial Accounting Standards Board, particularly ASC Topic 820. The staff of the SEC also has provided guidance on valuation issues through a series of no-action letters.

    Section 2(a)(41) of the 1940 Act defines “value” with respect to assets held by registered investment companies.[3] The definition differentiates between assets for which market quotations are “readily available” and those for which market quotations are not readily available. When market quotations are not readily available, value is defined as fair value as determined in good faith by the regulated fund’s board of directors.

    The SEC notes in the Release that since the issuance of the ASRs, there have been significant changes in market and investment practices impacting regulated funds and the valuation of their investments, as well as several regulatory changes. Regulated funds now invest in more complex securities that present new valuation challenges. As an example, BDCs, which did not exist when the ASRs were issued, typically invest in the securities of small and middle-market companies that must be fair valued on at least a quarterly basis. The Release also notes that communications and technology advances have also resulted in greater availability of pricing information, as well as greater availability of other data that may be relevant in the valuation process.

    The enactment of the Sarbanes-Oxley Act of 2002, which established the Public Company Accounting Oversight Board, the adoption of Rule 38a-1 under the 1940 Act requiring regulated funds to adopt compliance policies and procedures (including with respect to fair value) and the issuance of ASC Topic 820 by the Financial Accounting Standards Board all have significantly impacted the regulated fund valuation process. These regulatory developments, coupled with more complex and harder to value securities held by regulated funds, have resulted in boards relying more heavily on the expertise of investment advisers and third-party pricing services in an effort to effectively fulfill the fair value determination obligations set forth in Section 2(a)(41). The Release notes that while boards currently are responsible for determining the methodologies used to fair value regulated fund investments, they typically rely on the adviser and third-party pricing services for the day-to-day calculation of fair values.

    Acknowledging the reality of current board practices and the developments discussed above, the Proposed Rule provides that the board may assign the fair valuation determination for investments to an investment adviser of the regulated fund (including a sub-adviser), subject to oversight of the board and certain reporting and recordkeeping requirements.[4] It also provides a standardized framework for the actions and functions that are required in order to determine fair value in good faith. In addition, the Proposed Rule provides a definition of “readily available market quotation,” which is not otherwise defined in the 1940 Act or the rules thereunder.

    Performance of Fair Value Determination

    As noted above, the board of a regulated fund is responsible for determining in good faith the fair value for regulated fund investments for which market quotations are not readily available.[5] The Release acknowledges that boards typically are not involved in the day-to-day valuation tasks that would be required to determine fair value and instead in practice often allocate this function to the regulated fund’s adviser, subject to the board’s supervision. In acknowledging this practical reality, the Proposed Rule would allow the board to assign the actual fair value determination to an investment adviser of the regulated fund, including sub-advisers, which would carry out the functions described in the above section, subject to the board’s oversight.

    • Oversight and Reporting. The Release makes it clear that, even where a board has assigned fair value determination to the adviser, the board retains responsibility for oversight of the adviser. The Release notes that boards should approach this oversight with a “skeptical and objective view,” particularly with respect to potential conflicts of interest, and that oversight should be an active process. The Release encourages board members to seek out relevant information as may be necessary to be fully informed about the regulated fund’s fair value process, with a goal of improving it. It also notes that the SEC expects that boards will utilize an appropriate “level of scrutiny” based on the regulated fund’s valuation risk, and that this scrutiny should be proportionate to the level of subjectivity involved in determining fair value for an investment. The Release expects that boards will periodically review the financial resources, technology, staff, expertise and compliance capabilities of the adviser with respect to determination of fair value, with an aim to evaluate the appropriateness of the fair value process.

    The Release also focuses on concerns relating to potential conflicts of interest that may arise as a result of the adviser or other service providers having incentives to improperly value regulated fund assets. It notes that a regulated fund’s adviser may benefit from improper valuations, which could increase fees or improve returns.

    Pursuant to the Proposed Rule, the adviser must provide to the board a written assessment of the adequacy and effectiveness of the adviser’s fair valuation process, on at least a quarterly basis.[6] The adviser must also provide prompt reporting to the board (within three business days) on matters that could materially affect the fair value of investments. As noted in the Release, a board must also inquire about any material matters of which the board becomes aware, and take reasonable steps to ensure they are addressed.

    • Specify Responsibilities. If fair value determination is assigned to an adviser, the adviser must specify the titles of the persons responsible for determining the fair value of the investment, and must reasonably segregate the process of making fair value determinations from the portfolio management of the regulated fund, in order to avoid potential conflicts of interest. Although the Release notes that portfolio managers may have relevant input into the process for determining fair value for investments, the inherent conflicts of interest that are present because portfolio management personnel are usually compensated based on the returns of the regulated fund make it inappropriate for a portfolio manager to make the fair value determination.
    • Records When Assigning. In addition to the recordkeeping requirements described above, when a board assigns fair value determination to the adviser, the regulated fund must also maintain copies of reports and other information provided to the board by the adviser, as well as a specified list of the investments (or investment types) whose fair value determination has been assigned to the adviser.

    Fair Value Determination Under the Proposed Rule

    In order to determine fair value in good faith of a regulated fund’s investment, as required by Section 2(a)(41), the Proposed Rule lays out the following actions and functions that are required to be undertaken either by the board, or if the board has assigned fair value determination to the adviser, by the adviser.

    • Assess and Manage Valuation Risks. The Proposed Rule requires the periodic assessment of material risks associated with valuation. The Release includes examples of the types and sources of such risks, including the types of investments held by a regulated fund, potential market or sector dislocations, the extent to which unobservable inputs are utilized in the valuation methodology and reliance on service providers and limitations of their experience. The Proposed Rule does not prescribe the specific valuation risks to be addressed, and instead requires that this assessment be based on the facts and circumstances of an individual regulated fund’s investments. While a regulated fund’s valuation risks should be re-assessed periodically, the Proposed Rule does not set a specific required frequency for assessment, which should instead depend on changes in regulated fund investments or in a regulated fund’s strategy or policies, among other things.
    • Establish and Apply Fair Value Methodologies. The Proposed Rule requires that an appropriate fair value methodology be selected and applied in a consistent manner to determine the fair value of investments.[7] In this regard, the key inputs and assumptions specific to each asset class or portfolio holding held by the regulated fund, as well as which methodologies would apply to new types of regulated fund investments in which a regulated fund intends to invest, must be specified. In addition, the appropriateness and accuracy of the selected methodologies must be reviewed periodically and adjusted as necessary. Under the Proposed Rule, circumstances necessitating the use of fair value would need to be monitored and criteria for determining when market quotations are no longer reliable would need to be put into place.
    • Test Fair Value Methodologies. Once selected, the appropriateness and accuracy of the fair value methodologies must be tested, with the Proposed Rule requiring the identification of testing methods to be used and minimum frequency of testing. However, the Proposed Rule does not prescribe the specific testing methods or frequency of testing that should be undertaken, and instead such matters will depend on the facts and circumstances of each regulated fund, as determined by the board or the adviser. The Release notes that the results of calibration and back-testing can be particularly useful and can help identify issues with methodologies applied by regulated fund service providers.[8]
    • Evaluate Pricing Services. The Release notes that, particularly with respect to more complex assets, regulated funds may rely on valuation information provided by third-party pricing services. The Proposed Rule requires the oversight and evaluation of such pricing services by the regulated fund’s board or adviser, including the establishment of a process for the approval, monitoring and evaluation of each pricing service provider and setting criteria for initiating price “challenges” (i.e., where a regulated fund disagrees with a price provided by a pricing service).[9]
    • Fair Value Policies and Procedures. The Proposed Rule requires that written policies and procedures that are reasonably designed to achieve compliance with the requirements described above be adopted and implemented to address the determination of the fair value of regulated fund investments. These policies and procedures are intended to help ensure that determination of fair value of regulated fund investments is accomplished in compliance with the Proposed Rule. Where the board has assigned fair value determinations to the investment adviser, the adviser must adopt and implement such procedures, which would be subject to board oversight pursuant to the requirements of Rule 38a-1 under the 1940 Act. The Release also notes that a regulated fund could adopt the Rule 2a-5 policies and procedures of the adviser in order to fulfill its obligations under Rule 38a-1 to adopt compliance policies with respect to fair value.
    • Recordkeeping. The Proposed Rule would require a regulated fund to maintain documentation supporting fair value determinations for at least five years from the time the determination was made (the first two years in an easily accessible place), as well as to maintain a copy of the regulated fund’s fair value policies and procedures that are in effect, or that were in effect at any time in the past five years, in an easily accessible place.

    Notably, many of the above actions and requirements have previously been implemented by illiquid-focused regulated funds, such as BDCs, which often utilize a committee of independent directors, either through the audit committee or a separate valuation committee, to oversee the regulated fund’s valuation process. In many cases, this board committee is tasked with approving, among other things, the engagement of third-party pricing services and changes to a regulated fund’s valuation policies and procedures. This group of independent directors also often previews with a regulated fund’s adviser and any third-party pricing services proposed valuations of illiquid investments prior to board determination of fair value.

    Other Provisions of the Proposed Rule

    Readily Available Market Quotations

    As discussed above, for purposes of determining value of an investment, Section 2(a)(41) of the 1940 Act differentiates between whether market quotations are “readily available” or not, but this term is not defined in the 1940 Act or the rules thereunder. The Proposed Rule would define a market quotation as being “readily available” for purposes of the 1940 Act only when the quotation is a quoted price (unadjusted) in active markets for identical investments that the regulated fund can access at the measurement date, provided that a quotation will not be considered to be readily available if it is not reliable. The Release notes that a quote would be considered unreliable under the Proposed Rule in circumstances where it would require adjustment under U.S. Generally Accepted Accounting Principles (“U.S. GAAP”) or where U.S. GAAP would require consideration of additional inputs in determining the value of the security. If a market quotation is not available, a fair value methodology must be utilized in valuing the investment, and such methodology must also be determined in accordance with U.S. GAAP.

    Rescission of Prior Commission Releases and Withdrawal of No-Action Letters

    As noted in the Release, the SEC recognizes that, in light of more recent accounting standards and pronouncements, previous SEC guidance, including ASR 113 and ASR 118, as well as certain no-action letters relating to valuation, are no longer necessary and are proposed to be rescinded or withdrawn.

    Transition Period

    In order to provide regulated funds and advisers with sufficient time to prepare for compliance with the Rule, the effective date of the Proposed Rule, if adopted, would be one year following the publication of the final rule in the Federal Register.

    Impact of the Proposed Rule on Boards and Advisers

    The Proposed Rule represents an effort to formalize a more realistic allocation of responsibility for fair value determination as between a regulated fund’s board and its adviser. The rule has the potential to significantly streamline the fair value process for certain regulated funds that may only hold illiquid investments on an infrequent basis, and may aid open-end regulated funds in better handling their determination of daily net asset value when they hold one or more illiquid investments from time to time. However, as the Proposed Rule and the Release make clear, a board that assigns fair value determination to the adviser still retains substantial responsibility to oversee and assess the valuation process. In addition, the Proposed Rule requires a delineation between the valuation and portfolio management functions at the adviser level if a board opts to delegate fair value determinations in accordance with the Proposed Rule. As a result, BDCs and other regulated funds that invest primarily in illiquid assets may be less likely to take advantage of the delegation of fair value determinations afforded under the Proposed Rule, particularly in view of the robust board procedures such regulated funds typically already have in place to handle quarterly valuations.

    The Proposed Rule also prescribes the information that must be reported by an adviser to a board in the case of assignment, including relating to any material conflicts of interest an adviser (or other service provider) may encounter in the valuation process and to the adequacy of the resources allocated to the valuation process. In addition, the Proposed Rule sets out specific responsibilities of boards and advisers with respect to oversight and evaluation of pricing services. Therefore, while the Proposed Rule should help to improve the overall valuation process, it may require boards and advisers to make changes to their current valuation processes to meet the functions and requirements specified in the rule. In addition, the Proposed Rule will eliminate certain flexibility with respect to valuation that regulated funds and boards currently enjoy, given the significant number of requirements in the rule.

    Potential Impact on Advisers

    While the Proposed Rule applies only to regulated funds regulated under the 1940 Act, there are certain elements of the rule and the Release that could be viewed as best practices for all advisers to consider adopting, particularly with respect to potential conflicts of interest in the valuation process. As the Release notes, to the extent a regulated fund’s board delegates fair value determinations to a regulated fund’s adviser, it is important that the adviser’s fair value determination function be segregated from the portfolio management of that regulated fund to the extent possible, in order to avoid potential conflicts of interest. Investment advisers may find it challenging to separate their portfolio management personnel from those making fair value determinations, not only from a resources perspective but also in view of the detailed knowledge a regulated fund’s portfolio manager likely has with respect to the illiquid investments a regulated fund holds. The definition of readily available market quotations contained in the Proposed Rule can also provide additional clarity to advisers of private regulated funds, and the requirement to evaluate and monitor pricing services in the Proposed Rule provides a reminder to all advisers of the importance of doing so.

    It is also very important for an adviser to be able to demonstrate that its valuation process was robust, and to address as many sources of data as possible (and, of course, to retain robust, contemporaneous records of the valuation effort).

    Next Steps

    The Release contains numerous questions posed at regulated funds and their boards and advisers contending with the challenges of valuation. Regulated funds and their boards and advisers should consider whether the Proposed Rule provides a useful framework to formalize current valuation practices, in light of the requirements imposed by the rule. The public comment period for the proposal will remain open until July 21, 2020.

    Authored by Karen Spiegel and Noah B. Aschen.

    If you have any questions concerning this Alert, please contact your attorney at Schulte Roth & Zabel or one of the authors.


    [1] Investment Company Act Release No. 33845 (April 21, 2020), available here.

    [2] These investments typically are valued using inputs categorized within Level 3 of the fair value hierarchy established by the Financial Accounting Standards Board in ASC Topic 820.

    [3] Section 59 makes Section 2(a)(41) applicable to BDCs.

    [4] Unit investment trusts, which do not have a board of directors, could assign the fair value determination to the trust’s trustee under the Proposed Rule.

    [5] See Section 2(a)(41)(B)(ii) of the 1940 Act. In ASR 118, the SEC acknowledged that the board may appoint a person to assist with the determination of fair value, but the findings must still be reviewed carefully by the board.

    [6] These reports must include a summary of, among other things, material valuation risks, including any material conflicts of interest of the investment adviser or other service providers, material changes to or material deviations from methodologies, testing results, adequacy of resources, material changes to the adviser’s process for overseeing pricing services and any other information requested by the board.

    [7] The Release notes that in order to be appropriate under the rule, a methodology must also be consistent with ASC Topic 820, which covers various valuation approaches and techniques, and should maximize the use of relevant observable inputs and minimize the use of unobservable inputs.

    [8] Calibration refers to the process of monitoring for material differences between the price paid for a fair valued holding as compared to the price calculated for such holding at the time of acquisition by the regulated fund’s fair value methodology. Back-testing compares the fair value of a regulated fund’s investment to observed transaction or other market information, including quotes from dealers or pricing services data.

    [9] The Release notes certain factors that should be considered in such an oversight process, including, among other things (i) the qualifications, experience and history of the pricing service, (ii) the valuation methods or techniques used by the pricing service for different asset classes, (iii) the process for considering price challenges, (iv) potential conflicts of interest of the pricing service and (v) the testing processes used by the pricing service.


    This communication is issued by Schulte Roth & Zabel LLP for informational purposes only and does not constitute legal advice or establish an attorney-client relationship. In some jurisdictions, this publication may be considered attorney advertising. ©2020 Schulte Roth & Zabel LLP.

    All rights reserved. SCHULTE ROTH & ZABEL is the registered trademark of Schulte Roth & Zabel LLP.

    In depth
    Authors
    More insights

  • HHS Announces Oversight of COVID-19 Response and Recovery Strategic Plan

    HHS Announces Oversight of COVID-19 Response and Recovery Strategic Plan

    ARTICLE / CLIENT ALERT

    HHS Announces Oversight of COVID-19 Response and Recovery Strategic Plan

    June 2, 2020

    Read time: 6 min

    Key takeaways
    Overview

    On May 26, 2020 the US Department of Health and Human Services (HHS) Office of Inspector General (OIG) published its Oversight of COVID-19 Response and Recovery Strategic Plan, identifying the agency’s four primary objectives during the Coronavirus (COVID-19) public health emergency (PHE). These goals, as articulated in the Plan, consist of protecting individuals, protecting financial resources, protecting infrastructure and promoting the effectiveness of HHS programs. The Plan indicates that enforcement activity will focus on the unprecedented funding mechanisms and regulatory flexibilities that were put in place around the COVID-19 PHE.

    The Plan’s components and strategic objectives will be of special interest to healthcare providers that availed themselves of regulatory flexibilities with a reimbursement impact, or that received response and recovery funding or otherwise benefitted from the financial relief mechanisms.

    In depth

    Focus #1 – Protecting Individuals

    OIG expressed its intent to issue guidance on the application of OIG’s administrative fraud enforcement authorities to support providers in delivering necessary patient care during the PHE. This arguably encompasses COVID-19-specific guidance issued by OIG, such as the policy statement regarding enforcement of the federal anti-kickback statute consistent with the Stark Law section 1135 waiver, and the creation of a novel “frequently asked questions” pathway to obtain OIG’s views on certain arrangements under OIG’s authorities.

    OIG further announced that it plans to conduct “rapid-cycle reviews” of conditions affecting HHS beneficiaries or providers while further deploying necessary law enforcement personnel to protect HHS personnel and resources. One prominent example of this rapid-cycle review may be the “pulse survey” OIG conducted concerning hospital experiences responding to COVID-19, which received significant public and administration attention due to its negative findings.

    In tandem, OIG will identify and investigate suspected fraud and other scams that jeopardize HHS beneficiaries and the public, including allegations of patient harm and testing and identity theft scams. Lastly, OIG will assess the impacts of HHS programs on the health and safety of beneficiaries and the public by conducting audits and evaluations in certain healthcare settings, such as nursing homes; HHS human services programs, such as child care programs; and other HHS operations, such as the acquisition, management and distribution of resources from the strategic national stockpile and the production, approval and distribution of COVID-19 tests, along with vaccine and treatment research and development.

    Focus #2 – Protecting Financial Resources

    As of mid-May 2020, HHS received $251 billion in appropriations for COVID-19 response and recovery, which includes $175 billion for the Provider Relief Fund and $76 billion for the HHS Office of the Secretary to prevent, prepare for and respond to the COVID-19 PHE. HHS also is spending a substantial amount from other appropriations for COVID-19-related activities, including increases in the federal match for Medicaid and in reimbursement for some Medicare services. Consequently, OIG has identified as a second area of focus its engagement in activities aimed to prevent, detect and remedy waste or misuse of COVID-19 response and recovery funds. These activities include conducting audits and evaluations of HHS’s oversight, management and internal controls for the award, disbursement and use of funds. Similarly, HHS intends to audit fund recipients to assess whether they appropriately met use, reporting and other requirements, and to recommend recovery of misspent funds. OIG is also prioritizing efforts to combat any fraud and abuse that diverts COVID-19 funding from its intended purpose or otherwise exploits emergency flexibilities granted to providers, as a further way to safeguard the use of government financial resources.

    Focus #3 – Protecting Infrastructure

    Cyberattacks against HHS, healthcare institutions and researchers have increased since the beginning of the COVID-19 PHE. In response, OIG made clear in the Plan that it is determined to combat research and intellectual property theft and protect the security and integrity of information technology (IT) systems and other healthcare technologies deployed in response to the PHE. OIG seeks to audit HHS capabilities for detecting IT vulnerabilities and identify whether known cybersecurity vulnerabilities related to networked medical devices, telehealth platforms and other technologies being used during the COVID-19 response have been mitigated. OIG also intends to investigate cybersecurity threats to, and attacks on, HHS systems and provide technical assistance to HHS to bolster and better protect its IT infrastructure.

    Focus #4 – Promoting the Effectiveness of HHS Programs

    In order to support the effectiveness of federal, state and local COVID-19 response and recovery efforts, OIG will conduct audits to evaluate these ongoing initiatives in order to ensure that recipients of funding achieve program goals. OIG also will identify successful practices and lessons learned from the COVID-19 response at the federal, state and local levels and make recommendations to strengthen future emergency preparedness and response. Of particular interest to providers, OIG intends to review pandemic preparedness planning to identify how preparedness funding was spent. Lastly, OIG will assess the emergency flexibilities that were authorized during the pandemic and their effects on HHS programs and beneficiaries, in order to inform program decisions after the PHE ends (e.g., impacts of expanded telehealth in Medicare during the emergency and implications for future Medicare policies).

    Key Takeaways

    The Plan encompasses OIG’s anticipated activity as the COVID-19 PHE becomes less acute and providers seek a return to pre-pandemic operating volumes. Providers should be mindful of the following factors in considering the Plan’s impact on their operations and compliance processes:

    • Increased audits and investigations are a unifying theme for OIG initiatives in the near future, particularly with respect to recipients of response and recovery funding.
      • Organizations receiving such funding should carefully document compliance with funding requirements and prepare for both upcoming public reporting to HHS and incoming audit requests related to such funding and such reports.
      • Organizations that have not carefully tracked their utilization of waivers and other regulatory flexibilities should consider doing so now, in order to prepare for any inquiries from OIG or other agencies regarding the organization’s operations during the COVID-19 PHE.
    • OIG’s plan also appears to contemplate increasing its “rapid-cycle” reviews, rather than relying on the more traditional audit and inspection process, which generally takes a long period of time for a report to be issued.
      • Organizations should be prepared for OIG contact for these reviews and for the potential consequent publicity from a quickly issued report.
      • Preparation should include the organization’s compliance team, counsel and leadership, with a communication process to ensure that the board or governing body is kept up-to-date on any reviews, their findings and the potential outcomes.
    Authors

    Tony Maida

    Partner

    New York – One Vanderbilt Avenue

    George Tzanetakos

    Partner

    Chicago

    More insights

  • Heads Up, Hospitals! As COVID-19 Approaches a Steady State, Accrediting Organizations Are Going Back to Work, Too

    ARTICLE / CLIENT ALERT

    Heads Up, Hospitals! As COVID-19 Approaches a Steady State, Accrediting Organizations Are Going Back to Work, Too

    June 2, 2020

    Read time: 5 min

    Key takeaways
    Overview

    As hospitals and healthcare facilities move toward an uneasy “new normal” and move to re-initiate services and procedures, accrediting organizations will also be ramping up their operations to pre-pandemic levels. However, review processes and standards are likely to reflect issues arising from the COVID-19 pandemic; as such, providers should plan accordingly for new procedures and questions designed to assess the safe provision of care.

    In depth

    Hospitals and healthcare facilities are well acquainted with the time and resources it takes to prepare for and respond to surveys and inquiries by accrediting organizations like The Joint Commission, DNV Healthcare, HFAP and the Center for Improvement in Healthcare Quality (CIHQ) (collectively, the AOs). During the public health emergency caused by the Coronavirus (COVID-19) pandemic (PHE), AOs took the unprecedented step of ceasing surveys for all but the most urgent activities, recognizing that providers were overextended given the emergent nature of the pandemic response and that their own survey teams could be put at risk in healthcare facilities treating COVID-19 patients or in group environments where asymptomatic spread was of heightened concern.

    As some of the most dire predictions about national morbidity and mortality have not yet materialized, and as facilities and providers have started moving toward an uneasy “new normal,” those facilities and providers are now getting back to work providing elective procedures and routine care and re-opening offices and service lines. Consistent with that shift, the AOs have also determined that it is time for them to return to work—even if that work looks a bit different than it has in the past.

    DNV Healthcare led the AO pack with its May 13, 2020, announcement regarding remote surveys for most provider types, and requested that providers still facing a COVID-19 surge or other special challenges related to the PHE reach out to ensure the organization knew what issues might impact the ability to participate in the survey process. DNV reiterated the importance of accreditation surveys in a time when increasing healthcare capacity—particularly for inpatient care—was needed, noting that remote surveys would be “followed up with full onsite surveys when it is safe to do so.”

    HFAP soon followed, with an advisory on May 15, 2020, announcing its plan to re-initiate survey activities after considering a provider’s COVID-19 information and prioritizing surveys based on “past deficiency reports, regional and local outbreak ‘hot spots,’ geographic location of available surveyors to compose an appropriate team, and state and/or local travel restrictions, among other criteria.”

    The largest AO released its plans on May 27, 2020. On that date, The Joint Commission (TJC) announced it would restart surveys and investigations effective in June 2020. Surveys will look different, inasmuch as surveyors will employ physical distancing practices, limit the numbers of individuals in group sessions, increase the use of audio or video conference calls to expand the number of attendees, and involve the use of masks and/or other personal protective equipment (PPE) provided by the facility or provider. Additional processes anticipated to be part of the survey process include electronic medical record reviews and a preference for simulations to replace live demonstrations that are not deemed safe.

    Of likely interest to providers accredited by The Joint Commission, the organization has indicated that it will “focus on a thorough assessment but will not retroactively review compliance,” suggesting that the renewed survey activity will not be focused on imposing a “20/20 hindsight” standard that could prove problematic given the exigencies that providers had to deal with at the height of the PHE. As noted in its May 27 announcement on the resumption of survey activity, surveys will focus on how providers have “adapted to the pandemic” and review current practices to assure provision of safe care in a safe environment.

    CIHQ has not posted a position statement on the resumption of survey activity, but is understood to have begun the process of performing reaccreditation surveys on a case-by-case basis.

    Key Takeaways

    As healthcare providers and facilities move to re-initiate services and procedures, AOs will also be ramping up their operations to pre-pandemic levels. Though neither the industry nor the AOs will be in “business as usual” mode any time soon, both look to adjust to the realities that the current state of the pandemic permits. In addition to concerns regarding the resources needed to prepare for and complete survey and investigation activity as AOs return to more typical operations, many providers are concerned about AOs retrospectively reviewing their processes and procedures during the height of the PHE without taking into account the realities in place at the time. While TJC has stated that it will “focus on a thorough assessment but will not retroactively review compliance”, it is not clear whether backlogged complaints or other triggers could lead to increased scrutiny of facilities’ pandemic operations, or if other AOs will take the same approach.

    Authors

    Sandra M. DiVarco

    Partner

    Chicago

    More insights

  • •	Guidelines for Equitable Employee Ownership Transitions

    • Guidelines for Equitable Employee Ownership Transitions

    ARTICLE

    • Guidelines for Equitable Employee Ownership Transitions

    June 1, 2020

    Read time: 1 min

    Key takeaways
    Overview
    In depth
    Authors
    More insights

  • The Next Normal—Tax Responses to COVID-19

    ARTICLE

    The Next Normal—Tax Responses to COVID-19

    May 30, 2020

    Read time: 1 min

    Key takeaways
    Overview
    In depth
    Authors
    More insights

  • The Next Normal—Tax Responses to COVID-19

    ARTICLE

    The Next Normal—Tax Responses to COVID-19

    May 30, 2020

    Read time: 1 min

    Key takeaways
    Overview
    In depth
    Authors
    More insights